Paradigm Biopharmaceuticals | PAR - Cash And Equivalent

Stock Price
0.20
Daily Change
0.01 2.63%
Monthly
-25.00%
Yearly
-33.90%
Q2 Forecast
0.22

Paradigm Biopharmaceuticals reported AUD16.82M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Avita Medical AUD 10.24M 1.98M Dec/2025
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Pacific Edge NZD 29.26M 8.79M Jun/2024
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Telix Pharmaceuticals AUD 207.16M 503.19M Jun/2025